Metalabs Posts 58 Billion Won in First-Half Sales, Up 187% YoY ... Turns Operating Profit Positive

KOSPI-listed Metalabs achieved both top-line growth and improved profitability in the first half of this year, driven by the expansion of its premium fashion business and the effect of consolidating subsidiaries.

Metalabs announced that its consolidated sales for the first half of 2026 reached 5.8 billion won, with an operating profit of 800 million won. Sales increased by 187% from 2.02 billion won in the same period last year, while operating profit turned positive from a 5.9 billion won deficit. EBITDA was 1.1 billion won.

The company also reported a significant improvement in profitability. The cost of goods sold ratio was reduced from 89% in the first half of last year to 84% this year, and the selling and administrative expense ratio dropped sharply from 40% to 15%. In the management consulting division, cost reductions outpaced the decline in revenue, which further contributed to enhanced profitability.

This improvement in performance is attributed mainly to the growth of the premium fashion business and the effect of consolidating subsidiaries such as Metacare. Metalabs plans to continue expanding its growth businesses centered on fashion and healthcare in the second half of the year, while also pursuing greater operational efficiency across subsidiaries.

In the healthcare segment, the company is accelerating the overseas expansion of K-beauty medical services. Its subsidiary Momolabs is working with local partners to open a medical facility in Dubai, United Arab Emirates, within the year, which will offer Korea-style hair loss treatment and hair transplant services.

In the mid- to long-term, the company aims to leverage its accumulated capabilities in medical institution management support and information technology from the domestic market to introduce specialized healthcare IT solutions at its Dubai medical facility, with plans to further expand into global medical institution operational platforms.

Subsidiary performance has also improved. Metacare recorded sales of 1.01 billion won, operating profit of 1.1 billion won, and net income of 600 million won for the first half of this year.

Starting from the second half of the year, the consolidated financial statements will also reflect the results of Techlabs, an AI-based ad tech and digital healthcare company in which Metacare has acquired the largest shareholder position and management rights. Techlabs recorded sales of 9.23 billion won and operating profit of 7.4 billion won last year.

Accordingly, once Techlabs is consolidated, it is expected that not only Metacare but also the highest-level holding company, Metalabs, will see further expansion in both consolidated top-line and profitability metrics.

A Metalabs representative stated, "We achieved both business expansion and a turnaround in operating profits by growing our new fashion business and consolidating subsidiaries," adding, "In the second half, we will strengthen the competitiveness of our premium fashion and healthcare businesses and further expand synergies among subsidiaries to continuously enhance both growth and profitability."

This content was produced with the assistance of AI translation services.